Gen-Wealth Partners’s Ginkgo Bioworks DNA Stock Holding History

Gen-Wealth Partners’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31	Hold	5	–	–	﹤0.01%	724
2025 Q4	$42	Hold	5	–	–	﹤0.01%	688
2025 Q3	$73	Hold	5	–	–	﹤0.01%	679
2025 Q2	$56	Hold	5	–	–	﹤0.01%	640
2025 Q1	$29	Hold	5	–	–	﹤0.01%	618
2024 Q4	$49	Hold	5	–	–	﹤0.01%	646
2024 Q3	$39	Sell	5 -1	-17%	-$10	﹤0.01%	657
2024 Q2	$77	Hold	6	–	–	﹤0.01%	645
2024 Q1	$268	Buy	+6	New	+$311	﹤0.01%	617

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gen-Wealth Partners's DNA Position: Q1 2026 in Review

Gen-Wealth Partners held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 5 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Gen-Wealth Partners first reported a position in DNA in Q1 2024 and has held it in 9 quarters since. The position peaked at $268 in Q1 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Gen-Wealth Partners held 5 shares of Ginkgo Bioworks worth $31 as of Q1 2026.
Gen-Wealth Partners left its Ginkgo Bioworks share count unchanged in Q1 2026.
Ginkgo Bioworks made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q1 2026, its #724 holding.
Gen-Wealth Partners first reported a position in Ginkgo Bioworks in Q1 2024 and has held it in 9 quarters since.
Gen-Wealth Partners's Ginkgo Bioworks position peaked at $268 in Q1 2024.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Gen-Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.